Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 9:17:1400118.
doi: 10.3389/fnmol.2024.1400118. eCollection 2024.

The dual role of TRPV1 in peripheral neuropathic pain: pain switches caused by its sensitization or desensitization

Affiliations
Review

The dual role of TRPV1 in peripheral neuropathic pain: pain switches caused by its sensitization or desensitization

Ning Gao et al. Front Mol Neurosci. .

Abstract

The transient receptor potential vanilloid 1 (TRPV1) channel plays a dual role in peripheral neuropathic pain (NeuP) by acting as a "pain switch" through its sensitization and desensitization. Hyperalgesia, commonly resulting from tissue injury or inflammation, involves the sensitization of TRPV1 channels, which modulates sensory transmission from primary afferent nociceptors to spinal dorsal horn neurons. In chemotherapy-induced peripheral neuropathy (CIPN), TRPV1 is implicated in neuropathic pain mechanisms due to its interaction with ion channels, neurotransmitter signaling, and oxidative stress. Sensitization of TRPV1 in dorsal root ganglion neurons contributes to CIPN development, and inhibition of TRPV1 channels can reduce chemotherapy-induced mechanical hypersensitivity. In diabetic peripheral neuropathy (DPN), TRPV1 is involved in pain modulation through pathways including reactive oxygen species and cytokine production. TRPV1's interaction with TRPA1 channels further influences chronic pain onset and progression. Therapeutically, capsaicin, a TRPV1 agonist, can induce analgesia through receptor desensitization, while TRPV1 antagonists and siRNA targeting TRPV1 show promise in preclinical studies. Cannabinoid modulation of TRPV1 provides another potential pathway for alleviating neuropathic pain. This review summarizes recent preclinical research on TRPV1 in association with peripheral NeuP.

Keywords: TRPV1; desensitization; molecular mechanisms; peripheral neuropathic pain; sensitization.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Structural and functional overview of TRPV1 activation and desensitization. TRPV1 is composed of three parts: intracellular N and C termini, six transmembrane domains (S1–S6), and a pore loop region formed between S5 and S6. It can be activated by various physical and chemical stimuli, such as noxious heat (>43°C), divalent cations, low pH, inflammatory mediators, and animal toxins. Activation of this channel leads to significant influxes of Ca2+ and Na+, causing neuronal depolarization and action potential discharge. Prolonged stimulation enhances TRPV1 activation, reducing neuronal excitability and resulting in near or complete insensitivity to subsequent stimuli, a phenomenon known as specific desensitization. Additionally, elevated intracellular calcium levels can activate the calcium-dependent protease calpain, which degrades cytoskeletal components within axons, leading to axonal structural damage and functional loss.

References

    1. Abdelkader N. F., Ibrahim S. M., Moustafa P. E., Elbaset M. A. (2022). Inosine mitigated diabetic peripheral neuropathy via modulating GLO1/AGEs/RAGE/NF-κB/Nrf2 and TGF-β/PKC/TRPV1 signaling pathways. Biomed. Pharmacother. 145:112395. doi: 10.1016/j.biopha.2021.112395, PMID: - DOI - PubMed
    1. Abrams R. M. C., Pedowitz E. J., Simpson D. M. (2021). A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults. Expert. Rev. Neurother. 21, 259–266. doi: 10.1080/14737175.2021.1874920, PMID: - DOI - PubMed
    1. Agarwal N., Taberner F. J., Rangel Rojas D., Moroni M., Omberbasic D., Njoo C., et al. . (2020). SUMOylation of enzymes and ion channels in sensory neurons protects against metabolic dysfunction, neuropathy, and sensory loss in diabetes. Neuron 107, 1141–1159.e7. doi: 10.1016/j.neuron.2020.06.037, PMID: - DOI - PubMed
    1. Akhilesh, Uniyal A., Gadepalli A., Tiwari V., Allani M., Chouhan D., et al. . (2022). Unlocking the potential of TRPV1 based siRNA therapeutics for the treatment of chemotherapy-induced neuropathic pain. Life Sci. 288:120187. doi: 10.1016/j.lfs.2021.120187, PMID: - DOI - PubMed
    1. Akopian A. N., Ruparel N. B., Jeske N. A., Hargreaves K. M. (2007). Transient receptor potential TRPA1 channel desensitization in sensory neurons is agonist dependent and regulated by TRPV1-directed internalization. J. Physiol. 583, 175–193. doi: 10.1113/jphysiol.2007.133231, PMID: - DOI - PMC - PubMed

LinkOut - more resources